Medexus Pharmaceuticals is based in Burlington, Ontario, Canada. It has raised $85M in total funding. Latest round: Growth.
Medexus Pharmaceuticals funding overview
Medexus Pharmaceuticals is based in Burlington, Ontario, Canada. Medexus Pharmaceuticals has raised $85M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Growth announced in September 2022. The round record for Medexus Pharmaceuticals runs through 2022; nothing later has been disclosed.
Medexus Pharmaceuticals at a glance
Total raised
$85M
Latest round
Growth
Latest round date
September 2022
Headquarters
Burlington, Ontario, Canada
Frequently asked about Medexus Pharmaceuticals funding
How much has Medexus Pharmaceuticals raised?
Medexus Pharmaceuticals has raised $85M in total disclosed funding across the rounds on record.
Who has invested in Medexus Pharmaceuticals?
No investors are named on the public record for Medexus Pharmaceuticals yet.
What was the latest Medexus Pharmaceuticals funding round?
The most recent disclosed round is a Growth, announced in September 2022.
Where is Medexus Pharmaceuticals based?
Medexus Pharmaceuticals is based in Burlington, Ontario, Canada.
When did Medexus Pharmaceuticals last raise?
The last disclosed Medexus Pharmaceuticals round closed in September 2022 at Growth.
Every Medexus Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Burlington at a similar stage.
